Here are the 424B prospectus supplements from Our Bond, Inc. (OBAI) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow OBAI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OBAI filings page.
Our Bond, Inc. amends its resale prospectus to reflect modifications to warrants held by Ascent Partners Fund LLC and changes to the Certificates of Designation for Series C and Series D preferred stock.
The supplement registers the resale of up to 34,073,681 shares of common stock in connection with the company’s Nasdaq Global Market direct listing. The company adjusted exercise prices on a total of 9,000,000 warrants retained by Ascent (in tranches ranging from $1.25 to $4.50) and cancelled certain other Ascent warrants totalling 16,291,902 warrants at specified strike prices. The Series D conversion price was set to $2.0265, and a collective 10% daily "leak-out" limit on conversion-share sales was added to both Series C and Series D Certificates, with an exception for sales at or above 115% of the prior day’s closing price.
Our Bond, Inc. registers the resale of up to 34,073,681 shares of common stock by registered stockholders in connection with its Nasdaq Global Market direct listing.
This Supplement discloses an amendment to a Warrant held by Ascent Partners Fund LLC: the Warrant originally covered 16,000,000 shares at an exercise price of $12.35, with 15,991,902 shares currently purchasable. By March 1, 2026, the company reduced the exercise price for 12,000,000 of those shares in three tranches to $2.25, $2.75 and $3.25 for 90 days, after which the price reverts to $12.35.